TRF2 promotes multidrug resistance in gastric cancer cells

Cancer Biology and Therapy

Volumn 5, Issue 8, 2006, Pages 950-956

  Ning, Hanbing ^a,b   Li, Tingting ^a   Zhao, Lina ^a   Li, Ting ^a   Li, Jichang ^b   Liu, Jie ^a   Liu, Zhiguo ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Adriamycin; DNA damage response; Etoposide; Gastric carcinoma; Multidrug resistance; Telomerase; TRF1; TRF2

Indexed keywords

DOXORUBICIN; ETOPOSIDE; TELOMERASE; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2;

ARTICLE; CANCER CELL; DNA DAMAGE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RNA INTERFERENCE; STOMACH CANCER; TELOMERE; UPREGULATION;

EID: 33751167241     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.8.2877     Document Type: Article

References (22)

1. Gatti L, Zunino F. Overview of tumor cell chemoresistance mechanisms. Methods Mol Med 2005; 111:127-48.
2. Fan D, Zhang X, Chen X, Mou Z, Hu J, Zhou S, Ding J, Wu K. Bird's-eye view on gastric cancer research of the past 25 years. J Gastroenterol Hepatol 2005; 20:360-5.
3. Broccoli D, Smogorzewska A, Chong L, de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 1997; 17:231-5.
4. de Lange T. Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-10.
5. Yoshimura SH, Maruyama H, Ishikawa F, Ohki R, Takeyasu K. Molecular mechanisms of DNA end-loop formation by TRF2. Genes Cells 2004; 9:205-18.
6. Kuranaga N, Shinomiya N, Mochizuki H. Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telomere elongation: An in vitro study. BMC Cancer 2001; 1:10.
7. Klapper W, Qian W, Schulte1 C, Parwaresch R. DNA damage transiently increases TRF2 mRNA expression and telomerase activity. Leukemia 2003; 17:2007-15.
8. Bradshaw PS, Stavropoulos DJ, Meyn MS. Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage. Nat Genet 2005; 37:193-7.
9. Wright WE, Shay JW. Telomere-binding factors and general DNA repair. Nat Genet 2005; 37:116-8.
10. Cai XJ, Zhang XY, Fan DM. Establishment of multidrug resistant gastric cancer cell line and its biological characteristics. Zhongguo Zhongliu Linchuang 1994; 2:67-69, (Chinese).
11. An HZ, Zhou SJ, Fan DM. Establishment and characteristics of an adriamycin resistant human gastric carcinoma cell line. Xiandai Xiaohua Bing Ji Neijing Zazhi 1997; 2:108-10, (Chinese).
12. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30:e47.
13. Nordfjall K, Larefalk A, Lindgren P, Holmberg D, Roos G. Telomere length and heredity: Indications of paternal inheritance. Proc Natl Acad Sci USA 2005; 102:16374-8.
14. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999; 283:1321-5.
15. Yajima T, Yagihashi A, Kameshima H, Kobayashi D, Hirata K, Watanabe N. Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells. Br J Cancer 2001; 85:752-7.
16. Liu D, O'Connor MS, Qin J, Songyang Z. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem 2004; 279:51338-42.
17. Lobrich M, Jeggo PA. Harmonising the response to DSBs: A new string in the ATM bow. DNA Repair (Amst) 2005; 4:749-59.
18. Shi Y, Han Y, Wang X, Zhao Y, Ning X, Xiao B, Fan D. MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells. Gastric Cancer 2002; 5:154-9.
19. Shen H, Pan Y, Han Z, Hong L, Liu N, Han S, Yao L, Xie H, Zhaxi C, Shi Y, Fan D. Reversal of multidrug resistance of gastric cancer cells by downregulation of TSG101 with TSG101 siRNA. Cancer Biol Ther 2004; 3:561-5.
20. Du J, Pan Y, Shi Y, Guo C, Jin X, Sun L, Liu N, Qiao T, Fan D. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int J Cancer 2005; 113:213-20.
21. Shain KH, Dalton WS. Cell adhesion is a key determinant in de novo multidrug resistance (MDR): New targets for the prevention of acquired MDR. Mol Cancer Ther 2001; 1:69-78.
22. Karlseder J, Hoke K, Mirzoeva OK, Bakkenist C, Kastan MB, Petrini JH, de Lange T. The telomeric protein TRF2 binds the ATM Kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol 2004; 2:E240.